Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy
Status:
Withdrawn
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the drug bevacizumab in combination with cetuximab.
Because this combination has not been tested in cancer patients before, results will be
analyzed to see what effects the combination of bevacizumab with cetuximab has on esophageal
cancer.